ReviewFrontiers in immunology2026
Autoimmune nodopathy associated with Sjögren's disease and nephrotic syndrome: a case report and literature review.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anti-contactin-1 (CNTN1) antibody-positive autoimmune nodopathy (AN) is frequently reported in association with membranous nephropathy; however, the co-occurrence with both Sjögren's disease and nephrotic syndrome represents an exceptionally rare comorbid phenotype. In this study, we explored the potential immunological links underlying this comorbidity and, in conjunction with a literature review, sought to identify diagnostic clues for AN. Case presentation: We report the case of a 45-year-old woman who presented with progressive numbness and weakness of all four limbs for 5 months, accompanied by xerostomia and bilateral lower limb edema. Nerve conduction studies demonstrated demyelinating features, and cerebrospinal fluid analysis revealed albuminocytologic dissociation. Serum testing was positive for anti-CNTN1 antibodies (titer 1:1000), along with nephrotic-range proteinuria (4.66 g/24 h) and positivity for anti-SSA52, anti-SSA60, and anti-SSB antibodies. The patient was ultimately diagnosed with anti-CNTN1 antibody-positive AN coexisting with Sjögren's disease and nephrotic syndrome. Following intravenous methylprednisolone therapy, her neurological symptoms improved significantly. Conclusion: This case highlights that, within an immune context characterized by B-cell hyperactivation, anti-CNTN1 antibodies may mediate immune injury to both the peripheral nerves and kidneys by targeting shared antigens. Clinicians should recognize key diagnostic clues, including massive proteinuria, postural tremor, and poor response to intravenous immunoglobulin, to facilitate early identification of AN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.